Production of TGF-β1 as a Mechanism for Defective Antigen-presenting Cell Function of Macrophages Generated in vitro with M-CSF by Lee, Jae Kwon et al.
ORIGINAL ARTICLE
IMMUNE NETWORK 27
Received on December 9, 2008. Revised on December 19, 2008. Accepted on December 24, 2008.
*Corresponding Author. Tel: 82-43-261-2826; Fax: 82-43-268-2732; E-mail: cklee@chungbuk.ac.kr
Keywords: macrophage, M-CSF, APC function, TGF-β1
Production of TGF-β1 as a Mechanism for Defective 
Antigen-presenting Cell Function of Macrophages Generated 
in vitro with M-CSF
Jae Kwon Lee
1, Young-Ran Lee
2, Young-Hee Lee
2, Kyungjae Kim
3 and Chong-Kil Lee
2*
1School of Science Education (Biology), 
2College of Pharmacy, Chungbuk National University, Cheongju, 
3College of Pharmacy, 
Sahmyook University, Seoul, Korea
Background: Macrophages generated in vitro using macro-
phage-colony stimulating factor (M-CSF) and interleukin 
(IL)-6 from bone marrow cells (BM-Mp) are defective in anti-
gen presenting cell (APC) function as shown by their ability 
to induce the proliferation of anti-CD3 mAb-primed synge-
neic T cells. However, they do express major histocompati-
bility (MHC) class I and II molecules, accessory molecules 
and intracellular adhesion molecules. Here we demonstrate 
that the defective APC function of macrophages is mainly 
due to production of TGF-β1 by BM-Mp. Methods: 
Microarray analysis showed that TGF-β1 was highly ex-
pressed in BM-Mp, compared to a macrophage cell line, 
B6D, which exerted efficient APC function. Production of 
TGF-β1 by BM-Mp was confirmed by neutralization experi-
ments of TGF-β1 as well as by real time-polymerase chain 
reaction (PCR). Results:  Addition of anti-TGF-β1 mono-
clonal antibody to cultures of BM-Mp and anti-CD3 
mAb-primed syngeneic T cells efficiently induced the pro-
liferation of syngeneic T cells. Conversely, the APC function 
of B6D cells was almost completely suppressed by addition 
of TGF-β1. Quantitative real time-PCR analysis also con-
firmed the enhanced expression of TGF-β1 in BM-Mp. 
Conclusion: The defective APC function of macrophages 
generated in vitro with M-CSF and IL-6 was mainly due to 
the production of TGF-β1 by macrophages.
[Immune Network 2009;9(1):27-33]
INTRODUCTION
Macrophages can be generated from bone marrow (BM) pro-
genitor  cells  by  culturing  in  the  presence  of  macro-
phage-colony  stimulating  factor  (M-CSF).  Although  M-CSF 
alone can induce differentiation of BM progenitor cells into 
macrophages,  the  combination  of  M-CSF  and  interleukin-6 
(IL-6) significantly enhances macrophage production from BM 
progenitors  (1).  The  macrophages  generated  in  vitro u s i n g  
M-CSF or M-CSF plus IL-6, however, appeared to be different 
from  normal  macrophages  isolated  from  tissues.  Although 
macrophages generated in vitro with M-CSF do express MHC 
class II molecules, numerous accessory molecules and inter-
cellular adhesion molecules, they are defective in APC func-
tion (2-4). It has also been shown that some members of the 
macrophage family suppress antigen presentation by dendritic 
cells (DCs) (5), or induce T cell anergy (6), suppression (7) 
or  apoptosis  (8).  Thus  it  has  been  suggested  that  differ-
entiation along divergent pathways influences the APC func-
tion of various cell types. For instance, thymic macrophages 
are a specialized subset of macrophages that can phagocytose 
apoptotic cells very efficiently, but have poor APC functioning 
(9). 
    The APC function of mature macrophages may be affected 
by a variety of factors including the micro environmental con-
dition of its development. As shown recently, acquisition of 
APC functioning of mature macrophages was significantly in-
fluenced during development by factors such as the presence 
of CC chemokines like Lkn-1, MIP-1α and RANTES together 
with  M-CSF  (10).  The  defective  APC  functioning  of  macro-
phages generated in vitro with M-CSF may also be linked to 
the  intrinsic  inability  of  the  macrophages  to  produce  cyto-
kines such as IL-12 or to express an invariant (Ii) chain of 
class  II  MHC  molecules  (2,3). TGF-β1 Production by M-CSF-generated Macrophages
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  I n  t h e  p r e s e n t  s t u d y ,  w e  d e m o n s t r a t e  t h a t  m a c r o p h a g e s  
generated  in  vitro w i t h  M - C S F  a n d  I L - 6  f r o m  B M  c e l l s  
(BM-Mp) produce TGF-β1 in a quantity that is sufficient to 
suppress the proliferation of anti-CD3 mAb-primed syngeneic 
T cells. A macrophage cell line B6D, which exerts efficient 
APC  function,  produces  much  less  TGF-β1  compared  to 
BM-Mp. The present study, together with other studies which 
demonstrated that TGF-β1 inhibits the proliferation of T and 
B-lymphocytes,  thymocytes  and  NK  cells  (11-15),  indicates 
that the defective APC function of BM-Mp is mainly attribut-
able  to  the  production  of  TGF-β1  by  BM-Mp. 
MATERIALS AND METHODS
Cells and cell culture
The mouse thymic stromal cell line, TFGD, producing M-CSF 
and  IL-6,  was  obtained  from  a  thymoma  mass  that  sponta-
neously  developed  in  a  p53-/-  mouse  system  as  described 
previously (4). A macrophage cell line, B6D cells, was ob-
tained by subculturing BM-Mp in a culture medium supple-
mented with the culture supernatant of TFGD (50%, final con-
centration) for a year. The cells were cultured in Dulbecco's 
modified  Eagle's  minimum  essential  medium  supplemented 
with 100 U/ml penicillin, 100μg/ml streptomycin, and 10% 
heat-inactivated  fetal  bovine  serum  (Hyclone,  Logan,  USA). 
Cytokines and monoclonal antibodies 
Recombinant human (rh) G-CSF, rhM-CSF, rhGM-CSF, rhTGF-
β1  and  mouse  IFN-γ w e r e  p u r c h a s e d  f r o m  P e p r o T e c h  
(Rocky Hill, NJ). The monoclonal antibodies (mAbs) recog-
nizing  murine cell  surface markers,  anti-CD11c (clone HL3) 
and  anti-CD69  (clone  H1.2F3)  were  purchased  from 
Pharmingen  (San  Diego,  CA).  Anti-Dec-205  and  anti-CSF1R 
w e r e  p r o v i d e d  b y  D r .  K .  K o m s c h l i e s  a n d  D r .  J .  K e l l e r  
(National  Cancer  Institutes,  Frederick,  MD),  respectively. 
Generation of BM-Mp 
BM cells were isolated from femurs of C57BL/6 mice, cultured 
in a medium containing the culture supernatant of TFGD cells 
(50%, final concentration) in a 100 mm petri dish overnight. 
Non-adherent cells were collected after gentle shaking, count-
ed, adjusted to 2×10
5 cells/ml with the same medium, dis-
tributed  in  each  well  of  a  6-well  tissue  culture  plate  (5 
ml/well), and then incubated for 3 more days. At days 4 and 
6 from the initiation of culture, non-adherent cells were re-
m o v e d  a f t e r  v i g o r o u s  s h a k i n g ,  a n d  t h e n  5  m l  o f  t h e  s a m e  
medium was added to the culture. After 8 days of culture, 
the  adherent  cells  were  harvested  by  gentle  pipetting  with 
ice-cold phosphate buffered saline (PBS) containing 0.5 mM 
ethylenediaminetetraacetic  acid  (EDTA).
Assessment of cell proliferation (XTT assay)
XTT (Sodium 3’-[1-(phenylaminocarbonyl)-3,4-tetrazolium]-bis 
(4-methoxy-6-nitro)  benzene  sulfonic  acid  hydrate)  (Sigma- 
Aldrich) was dissolved in PBS (1 mg/ml), and stored at 4
oC. 
XTT working solution was prepared just prior to use by mix-
ing 1 ml of XTT stock solution with 5μl of PMS (N-methyl 
dibenzo-pyrazine  methyl  sulfate,  5  mM  in  PBS)  (Sigma- 
Aldrich). The XTT working solution was added to wells of 
cell culture (50μl/well), incubated at 37
oC for 4 h, and the 
absorbance was measured using an ELISA plate reader at 460 
nm  (DynaTech  MR5000). 
Phenotypic analysis
Cells  were  stained  with  monoclonal  antibodies  recognizing 
murine cell surface markers as described previously (4), and 
flow cytometric analysis was performed using a FACSCalibur 
(Becton-Dickinson). Dead cells were gated out by their low 
forward angle light scatter intensity. In most analysis, 10,000 
cells  were  scored.
Measurement of APC function
The APC function of macrophages was determined by testing 
their ability to stimulate proliferation of anti-CD3 mAb-primed 
syngeneic T cells, as described previously (4). Briefly, puri-
fied T cells (1×10
6 cells/ml) were mixed with anti-CD3 mAb 
(50 ng/ml; PharMingen), and then 100 μl of the cell suspen-
sion was added to each well of 96-well plates. Macrophages 
were  treated  with  mitomycin-C  (Sigma)  for  20  minutes  at 
37
oC, washed, and then indicated amounts of the cells were 
added  to  each  well.  DNA  synthesis  was  measured  by 
[
3H]-thymidine (DuPont Pharmaceuticals, Wilmington, DE) in-
corporation (0.5 μCi/well) for the final 8 h of the 3-day cul-
ture  period. 
Microarray analysis
RNA was isolated from BM-Mp and B6D cells using an RNA 
extraction system (RNeasy: Qiagen, Valencia, CA). Prepara-
tion of probes and hybridization processes were performed 
essentially as previously described (16) Briefly, cDNAs were 
synthesized from total RNAs by random-primed reverse tran-
s c r i p t i o n  i n  t h e  p r e s e n c e  o f  C y 3 - U T P  o r  C y 5 - U T P .  T h e  TGF-β1 Production by M-CSF-generated Macrophages
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Figure 1. Effects of various cytokines on
the growth of B6D cells. B6D cells were
cultured in the presence of the indicated
amounts of the culture supernatant of 
TFGD cells (A) or with the indicated 
cytokines (B) for 3 days. The proli-
feration of B6D cells was determined by 
an XTT assay. The results show the 
mean±S.D. of three independent experi-
ments.
f u l l - l e n g t h  e n r i c h e d  m o u s e  c D N A  m i c r o a r r a y s  w e r e  h y b r i -
dized with labeled cDNA probes overnight at 65
oC, and then 
washed in 2×SSC/0.1% SDS, washed in 1×SSC, and finally 
washed in 0.1×SSC. Then, these slides were scanned on a 
Scan Array 5000 confocal laser scanner, and the images were 
analyzed  using  ImaGene  (BioDiscovery). 
Real-time PCR
One microgram of RNA isolated from BM-Mp and B6D cells 
was used to prepare cDNA with a TaqMan Reverse Transcrip-
tion kit (Applied Biosystems, Branchburg, NJ). One microliter 
of each cDNA sample was then used for quantification using 
the SYBR Green PCR master mix (Applied Biosystems) and 
reactions were run on the ABI Prism 7700 Sequence Detector 
(Applied Biosystems). The results were normalized to GAPDH 
using the Quantum RNA universal 18S (Ambion, Austin, TX) 
and  were  also  used  to  determine  relative  quantities.  The 
probe, TGCACAGCTCACGGCACCGG, was labeled at the 5’ 
end  with  6-carboxyfluorescein  (6-FAM)  and  contained  the 
quencher dye 6-carboxy-N,N,N’,N’-tetramethylrhodamine (TAMRA) 
at the 3’ end. The forward primer was 5’-TGGAAAGGGCC-
CAGCAC-3’, and the reverse primer was 5’-GCAATAGTTG-
GTATCCAGGGCT-3’.  The  relative  level  of  TGF-β1  mRNAs 
was  calculated  as  described  by  Liu  and  Saint  (17). 
RESULTS
Establishment and characterization of a macro-
phage cell line, B6D
BM-Mp, which was generated from BM cells of C57BL/6 mice 
by culturing in a medium containing the culture supernatant 
of  TFGD  cells  (50%,  final  concentration),  was  continuously 
subcultured in a medium supplemented with the culture su-
p e r n a t a n t  o f  T F G D .  A f t e r  a  y e a r  o f  s u b c u l t u r e ,  t h e  m a c r o -
phages, named B6D, exhibited M-CSF-dependency as well as 
TFGD-supernatant-dependency in the growth pattern (Fig. 1). 
Flow  cytometric  analysis  showed  that  B6D  cells  expressed 
CD11b, CD24, CD44, CD45, CD54, MHC class II (I-A
b), CD80, 
CD86 and CD40 to a level similar to that of BM-Mp which 
was freshly generated from BM cells using TFGD-supernatant 
(data not shown). However, the expression levels of DEC205, 
CSF-R1,  CD69  and  CD11c  were  significantly  higher  in  B6D 
cells compared to that of freshly generated BM-Mp (Fig. 2). 
Comparison of the APC function of B6D cells and 
BM-Mp
The APC function of B6D cells and BM-Mp was comparatively 
studied by testing their ability to induce proliferation of syn-
geneic  anti-CD3  mAb-primed  T  cells.  Consistent  with  pre-
vious observations (4), BM-Mp cells were defective in induc-
ing proliferation of syngeneic anti-CD3 mAb-primed T cells. 
However, B6D cells efficiently enhanced the proliferation of 
syngeneic  anti-CD3  mAb-primed  T  cells  (Fig.  3).  The  pro-
liferation-inducing activity of B6D cells was most potent when 
the ratio of B6D cells and syngeneic anti-CD3 mAb-primed 
T  c e l l s  w a s  1 : 1 0 .  
Microarray analysis of the differential gene expres-
sion between B6D cells and BM-Mp
To examine any differences in gene expression between B6D 
cells and BM-Mp, mRNAs were isolated from each cell type, 
and then cDNAs were synthesized from total mRNAs by ran-
dom-primed reverse transcription in the presence of Cy3-UTP 
(green color) or Cy5-UTP (red color). The microanalysis plate TGF-β1 Production by M-CSF-generated Macrophages
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Figure 2. Phenotypic differences between BM-Mp and B6D cells. The
cells were stained with the indicated mAbs, washed and analyzed by
flow cytometry. Levels of expression (thin line) were illustrated in 
comparison to isotype control (dotted line).
Table I. Microarray analysis for the differential expression of 
genes between B6D cells and BM-Mp
Green-Cy3-B6D
Red-Cy5-BM-Mp
Green-Cy3-BM-Mp
Red-Cy5- B6D
Genes R/G  ratio
a Genes R/G  ratio
Mannose receptor, C type1 7.57 Glycoprotein 49 B 0.11
TGF-β1 7.10 Mannose receptor, C type 1 0.11
Fc receptor. IgG 6.59 Fc receptor, IgG 0.10
Fatty acid binding protein 6.27 Fatty acid binding protein 0.08
Interleukin 7 receptor 5.35 TGF-β10 . 0 7
aR/G ratio indicates the fluorescence ratio of red (Cy5) vs green 
(Cy3).
Figure 3. Comparison of the APC functions of BM-Mp and B6D cells.
Syngeneic anti-CD3 mAb-primed T cells (1×10
5 cells/well) were 
cultured with the indicated number of BM-Mp or B6D cells. 
Proliferation of T cells was measured by [
3H]-thymidine incorporation
for the final 8 h of the culture period of 3 days. The results show
the mean±S.D. of three independent experiments.
contained 1,200 genes. To confirm the differential expression 
of genes, microarray analysis was repeated with the cDNAs 
reversely labeled with the dyes. Microarray analysis identified 
approximately  89  genes  that  were  differentially  expressed 
(data not shown). The genes that were profoundly different 
in expression are shown in Table I. Among these, TGF-β1, 
which was highly expressed in BM-Mp compared to B6D cell, 
was  selected  for  further  experiments,  because  TGF-β1  has 
been known to inhibit immune responses in a variety of sys-
tems  (11-15). 
Effects of blocking or addition of TGF-β1 on the APC 
function of macrophages
To confirm that TGF-β1 produced from BM-Mp was respon-
sible for the defective APC function of BM-Mp, two experi-
ments, blocking of TGF-β1 with anti-TGF-β1 mAbs and ad-
dition of TGF-β1, were performed. As shown in Fig. 4, addi-
tion of anti-TGF-β1 mAbs to mixed cultures of BM-Mp and 
anti-CD3 mAb-primed syngeneic T cells dose-dependently in-
creased the proliferation of T cells. Conversely, addition of 
TGF-β1  to  mixed  cultures  of  B6D  cells  and  anti-CD3 
mAb-primed syngeneic T cells dose-dependently inhibited the 
proliferation of T cells (Fig. 5). These results indicated that 
TGF-β1 produced from BM-Mp was responsible for the de-
fective  APC  function  of  BM-Mp. 
Quantitative comparison of the expression of TGF-β1 
mRNA
In order to compare the expression of TGF-β1 mRNA more 
accurately,  real  time  PCR  analysis  was  performed  with  the 
cDNAs  obtained  from  BM-Mp  and  B6D  cells.  The  quantity 
of  mRNA  was  compared  by  the  values  of  2
−ΔΔCT ( r e l a t i v e 
l e v e l ) .  A s  s h o w n  i n  T a b l e  I I ,  B M - M p  e x p r e s s e d  a  2 . 8 - f o l d  
higher level of TGF-β1 mRNA compared to B6D cells under 
unstimulated conditions. The ratio of difference in expression 
of  TGF-β1  mRNA  was  not  significantly  altered  after  stim-
ulation with LPS (100 ng/ml), or IFN-γ (100 U/ml). The vari-
ability  between  triplicate  assays  of  the  same  cDNA  sample 
was  typically  less  than  5%.
DISCUSSION
The present study investigated the possible cause of defective TGF-β1 Production by M-CSF-generated Macrophages
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Figure 5. Inhibition of the APC function of B6D cells by addition of 
TGF-β1. Syngeneic anti-CD3 mAb-primed T cells (1×10
5 cells/well) 
were culture with B6D cells (1×10
4 cells/well) in the presence of the
indicated amounts of rhTGF-β1. The results show the mean±S.D. of
three independent experiments.
Table II. Expression of TGF-β1 mRNA
ΔCT ΔΔCT 2
−ΔΔCT (Relative level)
No stimulation BM-macrophage 1.93 0 1
B6D cell 3.43 1.509 0.351
LPS (100 ng/ml) BM-macrophage 1.89 0 1
B6D cell 3.30 1.408 0.377
IFN-γ (100 U/ml) BM-macrophage 1.90 0 1
B6D cell 3.62 1.715 0.305
RNA samples were isolated from BM-Mp and B6D cells that were stimulated with LPS or IFN-γ  for 48 h, and then used to generate the
corresponding cDNA samples. Real time PCR reactions were run on an ABI Prism 7700 Sequence Detector (Applied Biosystems) with 
the probes described in the Methods section. Relative gene expression levels were calculated as described by Liu and Saint (17).
Figure 4. Recovery of APC function of BM-Mp by blocking with 
anti-TGF-β1 mAb. Syngeneic anti-CD3 mAb-primed T cells (1×10
5
cells/well) were cultured with BM-Mp (1×10
4 cells/well) in the 
presence of the indicated amounts of anti-TGF-β1 mAb. IgG is an 
isotype control for anti-TGF-β1 mAb. The results show the mean±
S.D. of three independent experiments. 
APC functioning of macrophages that were generated in vitro 
using M-CSF. Macrophages are usually strongly phagocytic for 
IgG-opsonized sheep red blood cells (SRBCs), produce nitric 
oxide  (NO)  in  response to  interferon IFN-γ plus LPS,  and 
express  cell  surface  molecules  that  are  known  to  be  asso-
ciated  with  mouse  macrophages  (2-4).  However,  macro-
phages generated from BM cells in vitro using M-CSF alone 
or in combination with IL-6 are defective in APC functions. 
Macrophages generated from CD34+ progenitors by cytokines 
produced from a renal carcinoma cell line were also shown 
to be defective in APC function, although they exerted pow-
erful phagocytic activity and expressed the same surface phe-
notype markers with peripheral blood macrophages (18). The 
renal carcinoma cell line was shown to produce M-CSF and 
IL-6 (18). This feature is unique, because DCs generated from 
BM cells or peripheral blood monocytes with GM-CSF exert 
strong  APC  functions  (19,20).
    To address the possible reasons for defective APC function-
ing of the macrophages generated in vitro using M-CSF, we 
compared differences in gene expression between a macro-
p h a g e  c e l l  l i n e  B 6 D ,  w h i c h  e x e r t e d  e f f i c i e n t  A P C  f u n c t i o n ,  
and that of macrophages generated from BM cells with M-CSF 
and IL-6. Microarray analysis showed that TGF-β1 was highly 
expressed  in  macrophages  generated  from  BM  cells  with 
M - C S F ,  c o m p a r e d  t o  B 6 D  c e l l s .  B l o c k i n g  e x p e r i m e n t s  w i t h  TGF-β1 Production by M-CSF-generated Macrophages
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anti-TGF-β1  mAbs  as  well  as  additional  experiments  with 
TGF-β1 confirmed that TGF-β1 produced by macrophages 
that were generated from BM cells in vitro using M-CSF was 
responsible  for  the  defective  APC  function.  Real  time  PCR 
analysis also confirmed that TGF-β1 was highly expressed in 
the macrophages generated by BM cells in vitro using M-CSF 
and  IL-6.
    Macrophages can be generated from CD34+ progenitors in 
vitro using M-CSF, which is a hematopoietic glycoprotein that 
stimulates the proliferation and differentiation of BM progeni-
t o r  c e l l s  i n t o  m y e l o i d  c e l l s .  M - C S F  p l a y s  a n  i m p o r t a n t  r o l e 
in monocyte/macrophage homeostasis (21,22). M-CSF, how-
ever, by itself is not effective in inducing macrophage differ-
entiation from BM progenitors (1,18). Earlier studies showed 
that M-CSF synergies with IL-6 in the generation of macro-
phages from BM progenitor cells (33,34,38). We used the cul-
ture supernatant of TFGD cells, which was shown to contain 
large  amounts  of  M-CSF  and  IL-6  (4),  to  produce  macro-
phages from BM progenitor cells in vitro. The macrophages 
generated by the culture supernatant of TFGD cells were de-
fective  in  APC  function,  as  shown  by  the  present  study  as 
well  as  by  an  earlier  study  (4). 
    One of the most potent activities of TGF-β1 on lympho-
cytes is its anti-proliferative effect. TGF-β1 inhibits the pro-
liferation of T lymphocytes and B-lymphocytes, thymocytes, 
large granular lymphocytes, and NK cells (11-15). Studies us-
ing  peripheral  blood  mononuclear  cells,  monocytes  and  T 
lymphocytes suggest that TGF-β1 may function as a strong 
inhibitor of the expression of many cytokines involved in the 
effector  functions  of  activated  cells  (11,15).  TGF-β1  was 
shown to inhibit the effects and/or the production of IFN-γ, 
TNF-α, TNF-β, IL-1, IL-2 and IL-3, as well as the expression 
of IL-2 receptor (22-25). Thus, the inhibition of cytokine activ-
ity  is  presumably  a  major  factor  in  TGF-β1-induced 
immunosuppression.  Further  evidence  of  the  strong  im-
munosuppressive effect of TGF-β1 on lymphocytes is the re-
ported downregulation of IFN-γ-induced MHC class II anti-
gen expression by TGF-β1 in both lymphoid and non-lym-
phoid cells (26). Taken together, the present study demon-
strated  that  TGF-β1  produced  from  the  M-CSF-generated 
macrophages was responsible for the defective APC function-
ing  of  the  macrophages. 
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